Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective

Publisher： Cambridge University Press

E-ISSN： 1741-203x|24|S1|S46-S50

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.24, Iss.S1, 2012-07, pp. : S46-S50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the standardized Ginkgo biloba extract EGb 761® on neuroplasticity

By  

International Psychogeriatrics, Vol. 24, Iss. S1, 2012-07 ,pp. : S21-S24

Cambridge University Press

Access to resources Recommend Favorite

Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®

By  

International Psychogeriatrics, Vol. 24, Iss. S1, 2012-07 ,pp. : S25-S34

Cambridge University Press

Access to resources Recommend Favorite

Gingko biloba extract EGb 761®: clinical data in dementia

By  

International Psychogeriatrics, Vol. 24, Iss. S1, 2012-07 ,pp. : S35-S40

Cambridge University Press

Access to resources Recommend Favorite

Mitochondrial effects of Ginkgo biloba extract

By  

International Psychogeriatrics, Vol. 24, Iss. S1, 2012-07 ,pp. : S18-S20

Cambridge University Press

Access to resources Recommend Favorite

Trajectories of cognitive decline in Alzheimer's disease

By  

International Psychogeriatrics, Vol. 22, Iss. 2, 2010-03 ,pp. : 281-290

Cambridge University Press

Access to resources Recommend Favorite